Nova Biopharma Private Limited

Nova Biopharma Private Limited - pharma in Jodhpur, Rajasthan, India. FY 2026 financials & compliance.
CIN U24232RJ2009PTC030484 Incorporated 14 December 2009 ROC Jaipur HQ Jodhpur, Rajasthan, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.78 Cr
▲ 8% YoY
Net loss · FY 2025
₹33,894
Net margin -0.2%
EBITDA · FY 2025
₹10.9 Lakh
EBITDA margin 6.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹12.49 Lakh
Secured borrowings
Company age
17 yrs
Est. 2009
Directors on board
2
As per MCA filings

About Nova Biopharma Private Limited

Data last updated:

Nova Biopharma Private Limited is a private limited company based in Jodhpur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 December 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2009PTC030484. Its GSTIN is 08AADCN6044P2ZY (Rajasthan). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jyoti Daga and Pushpa Daga.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 38 Shiva Sadan Dharm Narayan Ji Ka Hatha Paota, Jodhpur, Rajasthan, India – 342001.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.78 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net loss of ₹33,894 (net margin -0.2%) and EBITDA of ₹10.9 Lakh (EBITDA margin 6.1%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 17% over five years.

As per MCA filings, the company has open charges of ₹12.49 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Nova Biopharma Private Limited
CIN U24232RJ2009PTC030484
Registration Number 030484
Incorporation Date 14 December 2009
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    B – 38 Shiva Sadan Dharm Narayan Ji Ka Hatha Paota, Jodhpur, Rajasthan, India – 342001
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Nova Biopharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Nova Biopharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Nova Biopharma Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Nova Biopharma Private Limited

The main business activity of Nova Biopharma is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Nova Biopharma Private Limited FY 2025 filings available

Nova Biopharma Private Limited reported revenue of ₹1.78 Cr (up 8% YoY) for FY 2025.

Revenue · FY 2025
₹1.78 Cr ▲ 8%
Net loss · FY 2025
₹33,894 margin -0.2%
EBITDA · FY 2025
₹10.9 Lakh margin 6.1%

Compounded Annual Growth Rate (CAGR) of Nova Biopharma Private Limited

Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 29%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▼ 12%
3 years · compounded
▲ 27%
5 years · compounded
▲ 60%

Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 8% growth in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Nova Biopharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹10.9 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹33,894••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Nova Biopharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin6.1%••••••••••••••••
Net Profit Margin-0.2%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nova Biopharma are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Nova Biopharma Private Limited

Nova Biopharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Biopharma, Formulations). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Squirrels Square Private Limited₹1.78 Cr (FY 2025)••••••••21.0%••••Hyderabad, Telangana, India
Richberg Healthcare Private Limited₹1.78 Cr (FY 2025)••••••••55.0%••••Panckula, Haryana, India
Metamed Laboratories Private Limited₹1.78 Cr (FY 2025)••••••••176.0%••••Mumbai, Maharashtra, India
S K Meditech Private Limited₹1.78 Cr (FY 2024)••••••••-9.0%••••Lucknow, Uttar Pradesh, India
I.Q. Med Healthcare Private Limited₹1.78 Cr (FY 2020)••••••••-55.0%••••New Delhi, Delhi, India
Nova Biopharma Private Limited this company₹1.78 Cr (FY 2025)••••••••8.0%••••Jodhpur, Rajasthan, India
Leogard Pharmaceuticals Private Limited₹1.77 Cr (FY 2025)••••••••-37.0%••••Kalyan, Maharashtra, India
Anmed Healthcare Private Limited₹1.77 Cr (FY 2025)••••••••-18.0%••••New Delhi, Delhi, India
Ontime Globe Kyarrier Private Limited₹1.77 Cr (FY 2021)••••••••12018.0%••••Pune, Maharashtra, India
Xtreme Laboratories Private Limited₹1.77 Cr (FY 2024)••••••••18.0%••••Rajkot, Gujarat, India
Velox Biologics Private Limited₹1.77 Cr (FY 2025)••••••••12.0%••••Chandigarh, India

Peers are the five companies nearest above and the five nearest below Nova Biopharma by revenue in the Pharma industry (Biopharma, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Nova Biopharma Private Limited

Nova Biopharma Private Limited is audited by A O P & CO for the financial year 2021.

NameStatusAppointment DateCessation Date
A O P & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Nova Biopharma Private Limited

Nova Biopharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Jyoti DagaDirector14 Dec 200916 Years 9 MonthsCurrent
Pushpa DagaDirector11 Apr 201115 Years 6 MonthsCurrent

Ownership and Shareholding of Nova Biopharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Nova Biopharma Private Limited

Open charges
₹12.49 Lakh
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹0.12 Cr
Latest charge details
DateLenderAmountStatus
17 Feb 2023Hdfc Bank Limited₹12.49 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Nova Biopharma Private Limited

Employment history and EPFO contributions of people linked to Nova Biopharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Nova Biopharma Private Limited

Nova Biopharma Private Limited has 3 board changes on record since 2009: 2 appointments and 1 cessation. The latest: Venkatesh Sharma ceased to be Director on 18 Apr 2011.

AGM
Nova Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nova Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 12.49 Lakh with Charge ID 100698557 was registered on 17 Feb 2023.
Ceased
Venkatesh Sharma ceased to be Director.
Appointed
Pushpa Daga was appointed as Director.
Appointed
Jyoti Daga was appointed as Director.
Incorporation
14 Dec 2009
Nova Biopharma Private Limited was registered on 14 Dec 2009 with Roc Jaipur & aged 16 years 9 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Nova Biopharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Nova Biopharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Nova Biopharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Nova Biopharma Private Limited

Nova Biopharma has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
08AADCN6044P2ZYRajasthanActive28 Jun 2018
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Nova Biopharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nova Biopharma Private Limited

Nova Biopharma is an active private limited company based in Jodhpur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 December 2009 (17+ years old) and is registered under CIN U24232RJ2009PTC030484.

Nova Biopharma reported revenue of ₹1.78 Cr for FY 2025 (up 8% YoY).

Nova Biopharma has 2 current directors:

Nova Biopharma reported a net loss of ₹33,894 (net margin -0.2%) and EBITDA of ₹10.9 Lakh (EBITDA margin 6.1%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Nova Biopharma is 29% over three years and 17% over five years. In the latest year (FY 2025) revenue rose 8%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Nova Biopharma is 08AADCN6044P2ZY, registered in Rajasthan. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Nova Biopharma is U24232RJ2009PTC030484. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nova Biopharma was incorporated on 14 December 2009, making it 17+ years old. It is registered with the Registrar of Companies, Jaipur.

The peers of Nova Biopharma by revenue are Squirrels Square Private Limited, Richberg Healthcare Private Limited, Metamed Laboratories Private Limited, S K Meditech Private Limited, I.Q. Med Healthcare Private Limited and 5 more, all in the Pharma industry (Biopharma, Formulations).

Venkatesh Sharma ceased to be Director on 18 Apr 2011. Pushpa Daga was appointed as Director on 11 Apr 2011. Jyoti Daga was appointed as Director on 14 Dec 2009.

The registered office of Nova Biopharma is at B – 38 Shiva Sadan Dharm Narayan Ji Ka Hatha Paota, Jodhpur, Rajasthan, India – 342001.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available